Skip to main content
. 2017 Sep 13;8(44):77897–77914. doi: 10.18632/oncotarget.20857

Table 2. Histopathological grading, EGFR-testing and EGFR-positivity in patients with AC.

Grade All AC patients (n=443) EGFR tested (n=265) EGFR-positive (n=44)
G1 38 (8.6%) 29 (10.9%) 9 (20.5%)
G2 97 (21.9%) 55 (20.8%) 15 (34.1%)
G3 248 (56.0%) 146 (55.1%) 12 (27.3%)
No grade given 50 (11.3%) 28 (10.6%) 4 (9.1 %)
Adenosquamous 10 (2.3%) 7 (2.6%) 4 (9.1%)